Order

Size
Price
Stock
Qty

PHA-767491

Axon 2690
CAS:  845714-00-3
Purity:  99%
  • Soluble in 0.1N HCl(aq) and DMSO
  • MF:  C12H11N3O
  • MW:  213.24

Description

PHA-767491 is an ATP-competitive dual inhibitor of the cell-cycle and transcriptional kinases CDC7 and CDK9, with IC50 values of 10 nM and 34 nM, respectively. PHA-767491 blocks DNA replication and pro-survival transcription, causing replication stress and cell death in cancer models. It shows preclinical antitumor activity and helps study T-cell function.

Key Features

  • Dual CDC7 and CDK9 kinase inhibitor
  • IC50: 10 nM for CDC7 and 34 nM for CDK9
  • Blocks replication-origin firing and transcriptional elongation
  • Induces replication stress and apoptotic cell death

Applications

  • CDC7 and CDK9 kinase research
  • DNA replication initiation and S-phase control
  • RNA polymerase II transcriptional regulation
  • MCL-1 and apoptosis studies
  • Cancer-cell and T-cell activation models

Related Products

AXON ID NAME FROM PRICE
1614 SNS 032

From $93.50

1776 Dinaciclib

From $99.00

1966 AZD5438

From $88.00

2268 XL 413 hydrochloride

From $132.00

3029 LDC000067

From $121.00

3184 SR-4835

From $143.00

3228 CDK inhibitor CR8

From $143.00

3402 THZ531

From $143.00

3525 ETP-47799

From $99.00

3730 KB-0742 dihydrochloride

From Inquiry

3800 AZD4573

From Inquiry

3801 Voruciclib

From Inquiry

3894 LY-3177833

From Inquiry

3935 BAY-1251152

From Inquiry

Loading...